InsiderSignal.AI

InsiderSignal.ai

ZLAB - Zai Lab Ltd

Insider Sale by Chen Yajing (CFO)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

2 days ago, Chen Yajing, serving as CFO at Zai Lab Ltd (ZLAB), sold 5,199 shares at $20.39 per share, for a total transaction value of $106,008.00. Following this transaction, Chen Yajing now holds 32,558 shares of ZLAB.

This sale represents a 14.00% decrease in Chen Yajing's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, April 2, 2026 and publicly disclosed via SEC Form 4 filing on Friday, April 3, 2026, 1 day after the trade was made.

Zai Lab Ltd operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Chen Yajing

Chen Yajing

CFO

Yajing Chen, Ph.D. is the Chief Financial Officer of Zai Lab Limited (NASDAQ: ZLAB), a commercial-stage biopharmaceutical company focused on oncology, autoimmune, infectious diseases, and neuroscience therapies.[[1]](https://www.zailaboratory.com/leadership/chenyajing/)[[2]](https://www.insidertrades.com/zai-lab-limited-stock/yajing-chen/)[[3]](https://lifesciencehistory.com/companies/zai-lab-limited/) She joined Zai Lab in September 2021 as Senior Vice President and Deputy CFO, and was promoted to CFO in July 2023.[[1]](https://www.zailaboratory.com/leadership/chenyajing/)[[2]](https://www.insidertrades.com/zai-lab-limited-stock/yajing-chen/)[[4]](https://www.biocentury.com/article/648496/zai-promotes-chen-to-cfo) Dr. Chen brings over 20 years of experience in the life sciences industry, previously at AstraZeneca from 2006 to 2021, where she served as CFO of the U.S. Oncology Business Unit (2019-2021) and Finance Controller of the Global Oncology Business Unit (2016-2019), driving financial planning, strategic development, and revenue growth in oncology.[[1]](https://www.zailaboratory.com/leadership/chenyajing/)[[2]](https://www.insidertrades.com/zai-lab-limited-stock/yajing-chen/) She holds a Ph.D. in Microbiology from New York University and an MBA from Columbia University.[[1]](https://www.zailaboratory.com/leadership/chenyajing/)[[2]](https://www.insidertrades.com/zai-lab-limited-stock/yajing-chen/)[[6]](https://rocketreach.co/yajing-chen-email_36897982) As a corporate insider, Dr. Chen owns approximately 19,999 shares of Zai Lab stock and earns an annual salary of $624,560.[[2]](https://www.insidertrades.com/zai-lab-limited-stock/yajing-chen/)

View full insider profile →

Trade Price

$20.39

Quantity

5,199

Total Value

$106,008.00

Shares Owned

32,558

Trade Date

Thursday, April 2, 2026

2 days ago

SEC Filing Date

Friday, April 3, 2026

Filed 1 day after trade

HEALTHCAREBIOTECHNOLOGY

About Zai Lab Ltd

Company Overview

No company information available
View news mentioning ZLAB

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/5335752

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime